ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Generic drug companies rework pricing to gain weight in India’s GLP-1 market as Novo Nordisk slashes Wegovy prices
Indian drugmakers are adjusting prices for weight-loss injections after Novo Nordisk cut prices for its drug Wegovy. This move is prompting generic companies to lower their expected launch prices. Novo Nordisk is also preparing to launch Ozempic in India s
Announcement as on 26 November 2025

Novo Nordisk's obesity drug shows weight loss of up to 14.5% in mid-stage study
Novo Nordisk said its new experimental obesity drug, amycretin, delivered up to 14.5% weight loss at 36 weeks in type 2 diabetes patients in a mid-stage trial. The drug was found to be safe with mostly mild gastrointestinal side effects, and the company pl
Announcement as on 25 November 2025

Novo Nordisk India prioritises patient outcomes; revenue growth follows naturally, says Shrotriya
Novo Nordisk India head Vikrant Shrotriya revealed a strategic 37% price cut for obesity drug Wegovy, aiming for wider accessibility. The company is preparing for semaglutide patent expiry next year by focusing on trust, quality, and education, mirroring
Announcement as on 19 November 2025

Patent expiry looms: Eli Lilly and Novo Nordisk strategise to defend their top obesity drugs in India
Eli Lilly and Novo Nordisk leaders share their India strategies for weight-loss drugs. They focus on pricing, market expansion and countering generics after semaglutide's patent ends. Both companies aim to increase patient access to their innovative thera
Announcement as on 18 November 2025

Novo Nordisk cuts weight-loss drug Wegovy's price by up to 33% in India, document shows
Novo and Lilly are locked in a race for dominance in India, a key battleground for weight-loss treatments in the booming global market, which analysts estimate could be worth 0 billion annually by the end of the decade. "This appears like prices have be
Announcement as on 11 November 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 46.2
  • 12Day Average: 45.63
  • 20Day Average: 43.53
  • 50Day Average: 40.15
  • 100Day Average: 45.83
  • 150Day Average: 47.17
  • 200Day Average: 49.11

NVO Indicators & signals

Indicator MACD (12,26,9)

45.09, 43.35, 1.67
Indicator MACD is in positive zone

Indicator ADX (14)

17.07, 33.57, 23.78
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Fri May 2026 44.74 44.25 to 45.50 -2.31% 0.94 times
14 Thu May 2026 45.80 45.54 to 46.84 -2.72% 0.76 times
13 Wed May 2026 47.08 46.65 to 47.21 0.17% 0.57 times
12 Tue May 2026 47.00 46.29 to 47.11 1.29% 0.82 times
11 Mon May 2026 46.40 46.27 to 47.79 0.72% 1.03 times
08 Fri May 2026 46.07 45.19 to 46.14 0.59% 0.69 times
07 Thu May 2026 45.80 45.75 to 47.08 0.11% 0.97 times
06 Wed May 2026 45.75 45.53 to 47.55 -0.02% 1.49 times
06 Wed May 2026 45.76 45.53 to 47.55 1.94% 1.78 times
05 Tue May 2026 44.89 44.21 to 45.12 1.13% 1.02 times
04 Mon May 2026 44.39 43.39 to 45.02 1.16% 0.86 times
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.51 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top